Estimated mean incremental cost per QALY at different battery life for... | Download Table
Study Population Flow Chart This flow chart shows the study population... | Download Scientific Diagram
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary | Circulation
Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study - ELLIS - 2016 - Pacing and Clinical Electrophysiology - Wiley Online Library
Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator | Circulation
PDF) Longevity of implantable cardioverter defibrillators: A comparison among manufacturers and over time
ATLAS: What do the Superiority Results Mean for S-ICD Therapy | ATLAS Study
2023 Canadian Cardiovascular Society Guidelines on the Fitness to Drive - Canadian Journal of Cardiology
Life | Free Full-Text | The CHA2DS2-VASC Score Predicts Mortality in Patients Undergoing Coronary Angiography
IJERPH | Free Full-Text | Vasovagal Syncope at Work: A Narrative Review for an Occupational Management Proposal
A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1 | SpringerLink
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care - Mullens - 2020 - European Journal of Heart Failure - Wiley Online Library
Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change | Circulation: Arrhythmia and Electrophysiology
Update on Arrhythmias and Cardiac Pacing 2013 | Revista Española de Cardiología
Diagnostics | Free Full-Text | Assessment of Left Atrial Structure and Function by Echocardiography in Atrial Fibrillation
PDF) Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA),
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study - ScienceDirect
How to follow a patient with heart failure and a biventricular device - Theofilogiannakos - 2016 - Continuing Cardiology Education - Wiley Online Library
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System | Journal of the American College of Cardiology
Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction - Journal of Cardiac Failure
Myocardial Minimal Damage After Rapid Ventricular Pacing – the prospective randomized multicentre MyDate-Trial | Scientific Reports
Circadian Rhythms of Early Afterdepolarizations and Ventricular Arrhythmias in a Cardiomyocyte Model - ScienceDirect
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet?
PDF) Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT
Implantable Defibrillators Improve Survival in Patients With Mildly Symptomatic Heart Failure Receiving Cardiac Resynchronization Therapy | Circulation: Arrhythmia and Electrophysiology
Reducing Ventricular Pacing Frequency in Patients With Atrioventricular Block | Circulation: Arrhythmia and Electrophysiology
